A developer that hit its marks

NexGen Energy, a Vancouver company whose only asset is the undeveloped Rook I uranium deposit in Saskatchewan's Athabasca Basin, has now cleared the hurdle that decides whether such projects exist at all. The Canadian Nuclear Safety Commission approved its environmental assessment and issued a licence to prepare the site and construct on 5 March 2026, 14 business days after hearings closed. NexGen took a final investment decision, raised roughly C$953m — about US$690m, and described as the largest equity financing in the sector's history — and awarded the shaft-sinking and underground engineering package, worth more than half the C$2.2bn (about US$1.6bn) capital estimate, at the figure it published in August 2024. Construction inflation has run hard across mining since; the number did not move. Site workforce is above 300, and first production is targeted around 2030.

The shares are down 12.3% since February. Market capitalization stands at $7.19bn against $8.01bn in mid-May, even though diluted shares rose from 570.0m to 705.3m over the year. Investors own nearly a quarter more of a materially de-risked asset for less money in aggregate. The financing is not finished: C$970m of liquidity funds well under half the build, with heavy spending deferred to early 2027 and project finance, government funding and customer prepayments all still under evaluation. NexGen has also chosen commodity exposure over certainty — 11.3m pounds committed at spot-indexed delivery prices, with 96% of the reserve base uncommitted.

Why that choice matters

Cameco, the world's largest publicly traded uranium producer and a 49% owner of reactor builder Westinghouse, is the counter-example. Its second-quarter realised uranium price rose 15% to C$93.13/lb — roughly US$68, well below a spot price near $88 and a long-term contract price stuck at $94, the highest since 2008. A fixed contract book signed in cheaper years is currently a drag on realisation, not a premium. Second-quarter revenue fell 7.2% to $814.1m, gross margin compressed to 21.1% from 29.3%, and net income fell 92% to $25.2m, with production of 3.9m pounds down 15% after spring road disruptions at Key Lake and McArthur River and a two-week suspension at Cigar Lake. Full-year production guidance of 19.5m to 21.5m pounds is unchanged.

Cameco's shares are down 15.5% over six months, yet the stock is more expensive than it was: 172.7 times trailing earnings against roughly 105x in early May, and 64.2 times trailing gross profit against 38x to 40x. Gross profit fell faster than the price. The forward multiple of 66.4x rests on 2027, not 2026, when consensus has revenue rising only 4.5%. The optionality is real — Westinghouse has confidentially filed a draft registration statement for a possible listing — but nothing has been given back on price.

The enricher's backlog outruns its shipments

Centrus Energy, the only American-owned commercial enrichment company, is where the scarcity story should be loudest. US utilities bought about 3.28m separative work units of Russian enrichment in 2025, close to 26% of their purchases, and the waiver regime ends in a full ban in 2028, with enrichment now near $160 per unit against about $40 before 2022. Centrus's backlog nearly doubled to $4.5bn through 2040, $2.4bn of it under definitive agreements, helped by a firm off-take with reactor developer X-energy. But second-quarter revenue growth of 14% came from reselling natural uranium; enrichment volumes fell 23% and gross margin dropped to 28.3%. New Western capacity is coming — Urenco is expanding its New Mexico plant by almost half — but not before 2029. Centrus's forward price/earnings of 74.6x sits above its trailing 74.2x, the reverse of a growth discount, because 2026 consensus earnings of $2.50 are 44% below last year's $3.90.

The month's trading points the same way. Over 30 days the miners led — Energy Fuels up 23.0%, Uranium Energy 22.5%, NexGen 15.0%, Cameco 13.4% — while Centrus added 6.9% and the reactor side fell, BWX Technologies down 10.5%. On 21 August the group gained 6% to 9% in a session with no company news and the S&P 500 up 0.2%. Cameco's 50-day average nonetheless sits below its 200-day for the first time in over a year. Money is moving down the stack, toward pounds — which is precisely the exposure NexGen has chosen and has not yet financed.

The setup

Where it stands — NexGen has permits, a budget held at estimate and a funding gap; Cameco and Centrus have de-rated without getting cheaper on profits. Would confirm — NexGen closes project financing covering the balance of the C$2.2bn build without a further equity issue. Would invalidate — A revised Rook I capital estimate above C$2.2bn, or first production guided past 2030. Watch next — Third-quarter results in November; freeze-system commissioning due early 2027 before heavy construction spend begins. Valuation — NexGen 5.38x book, no earnings multiple; Cameco 172.7x trailing and 66.4x forward against ~105x in May.